1. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. Issue 5 (October 2015) Authors: Duffy, AG; Ulahannan, SV; Cao, L; Rahma, OE; Makarova-Rusher, OV; Kleiner, DE; Fioravanti, S; Walker, M; Carey, S; Yu, Y; Venkatesan, AM; Turkbey, B; Choyke, P; Trepel, J; Bollen, KC; Steinberg, SM; Figg, WD; Greten, TF Journal: United European Gastroenterology journal Issue: Volume 3:Issue 5(2015:Oct.) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. Issue 5 (1st October 2015) Authors: Duffy, AG; Ulahannan, SV; Cao, L; Rahma, OE; Makarova-Rusher, OV; Kleiner, DE; Fioravanti, S; Walker, M; Carey, S; Yu, Y; Venkatesan, AM; Turkbey, B; Choyke, P; Trepel, J; Bollen, KC; Steinberg, SM; Figg, WD; Greten, TF Journal: United European Gastroenterology journal Issue: Volume 3:Issue 5(2015:Oct.) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. (19th November 2019) Authors: Horwich, A; Babjuk, M; Bellmunt, J; Bruins, H M; Reijke, T M De; Santis, M De; Gillessen, S; James, N; Maclennan, S; Palou, J; Powles, T; Ribal, M J; Shariat, S F; Kwast, T Van Der; Xylinas, E; Agarwal, N; Arends, T; Bamias, A; Birtle, A; Black, P C Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗